Resources Resource Type All Resources Poster (10) Presentation (5) Publication (27) Year All Years 2025 (4) 2024 (6) 2023 (6) 2022 (2) 2021 (5) 2020 (4) 2019 (1) 2018 (3) 2014 (3) 2011 (3) 2009 (1) 2007 (1) 2006 (1) 2005 (2) Search Found 42 Results November 10, 2021 Pharmacokinetics of First and Repeated Dosing of Anti-CTLA-4 Monoclonal Antibody ONC-392 in Advanced Cancer Patients Read more November 10, 2021 First-in-human study of the first acid pH sensitive and recycling CTLA 4 antibody ONC392 that preserves the immune tolerance checkpoint to avoid immunotherapy related adverse events in patients with advanced solid tumor (PRESERVE 1, NCT04140526) Read more November 10, 2021 Molecular Insights on Safety and Anti-tumor Activity ofAnti-CTLA-4 Monoclonal Antibody ONC-392 Read more February 9, 2021 Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma. Read more July 30, 2020 Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer. Read more April 1, 2020 Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin. Read more «23456»
